Sherrie Aspinall, PharmD, MSc, BCPS - Center for Health Equity Research and Promotion
Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Center for Health Equity Research and Promotion

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
EBenefits Badge
 

Sherrie Aspinall, PharmD, MSc, BCPS

CHERP COIN Investigator

Clinical Pharmacy Specialist, VA Center for Medication Safety

Associate Professor, University of Pittsburgh, School of Pharmacy, Department of Pharmacy and Therapeutics

Profile

Sherrie L. Aspinall, PharmD, MSc, BCPS is a core faculty member of the VA Center for Health Equity Research and Promotion (CHERP) at VA Pittsburgh Healthcare System and a clinical pharmacy specialist and PGY2 Residency Program Director in Medication Use Safety with the VA Center for Medication Safety (VA MedSAFE). She is also an Associate Professor in the School of Pharmacy at the University of Pittsburgh.

Dr. Aspinall has successfully mentored numerous pharmacy residents throughout her career with the VA as both a residency program director and preceptor. As a well-trained researcher in the areas of pharmacoeconomics, health services, and outcomes research, her work with CHERP and VA MedSAFE focuses on the safe, appropriate, and cost-effective use of medications. Dr. Aspinall has conducted multicenter studies to examine these issues in medications with safety concerns, such as warfarin, erythropoiesis-stimulating agents, and chemotherapy. In addition, she has utilized large databases to assess the impact of policy changes on safe and effective medication prescribing throughout the VA. Much of her work focuses on the elderly, who are a vulnerable population.

Research Areas

  • Medication Use Safety
  • Pharmacoeconomics